EUROSTARS Development of an innovative biosensor for continuous glucose monitoring with long operational life

GLUCARE consortium aims at seizing a major market opportunity by developing a first-of-its-kind long-term (+2 years) implantable biosensor for continuous glucose monitoring (CGM), that will provide patients with real time measurements for effective diabetes disease management. In this project, we will further advance the technology development by producing and validating a functional prototype for a CGM biosensor with an innovative surface coating – GP5 – that will significantly reduce adverse reactions, inflammation and improve subcutaneous residency time. At the end of GLUCARE, we expect to deliver a fully developed prototype, tested in in animal models, and ready to progress for clinical validation.